The Technology
Products · Electrokinetic Transdermal
Active Bandage Dental — Ionto-Pad Cosmeceutical
Products · Corona Electrostatic Precipitation
Respiratory — Mask Air Purification — HVAC Room Sanitization
Products · Regenerative
Stem Cell Machine Why It’s Different
Company
The Inventor Team Patents & Publications Engineering Renderings News Industries & Use Cases Partner With Us →
Biodefense · built for the field

Protect. Treat. Bring them home.

Henley Ion builds needle-free, field-ready biodefense technology — stopping bleeding, fighting infection, and managing pain at the point of injury, and shielding the lungs from airborne and CBRN threats. Independently validated. Patent-protected. Built to work where help is hours away.

Validated at Tulane and LSU · the delivery mechanism has an FDA-cleared predicate device, supporting a 510(k) pathway · 44-patent portfolio.
99.8%
Aerosolized SARS-CoV-2 removed in Tulane testing
44
U.S. patents in Dr. Henley's portfolio
7
Products across two platforms + a regenerative device
2
Independent university validations — Tulane & LSU

What the technology does

The same core technology treats the body and cleans the air. That’s why one company can build across both.

Electrokinetic Transdermal · into the body
Corona Electrostatic Precipitation · into the air
Why it’s different

Simple to make. Advanced in care.

The whole value of Henley Ion sits in one contrast: a device built from a few simple, single-use parts that delivers treatment normally reserved for a clinic.

Simple & disposable to make

A handful of disposable parts

Exploded view of the Active Bandage
A central hub, a squeeze-bulb medication port, two flexible electrode wings, and a sealing backing — no needles, no pump, no cold chain.
A few disposable parts — a central hub, a squeeze-bulb port, and two printed electrode wings.
No cold chain, no complex assembly — stores and ships like a plaster.
Scales to volume — reaching the field, the ER, and the developing world.
Advanced in treatment & care

Clinic-grade delivery, on the skin

Needle-free, sub-dermal delivery via multichannel iontophoresis — a gentle, targeted current.
Three jobs at once — mitigate infection, slow bleeding, and manage pain.
Extends the “golden hour” to golden days — continuous treatment where care is far away.
Concentrated, localized, clean, painless — independent channels avoid current “tunneling.”
The investable ratio

Simple, disposable production and clinic-grade care — strong margins, a large unmet market, and real human impact.

Why it’s different, in full →
How it works

Three steps, from wound to treatment.

1

Seal

Place the bandage over the wound. A conforming bladder seals it — stopping bleeding and fluid loss — anywhere on the body.

2

Squeeze to activate

Squeeze the bulb to deliver medication — antimicrobial, anesthetic, or clotting agent — through the port while the bandage stays sealed.

3

Deliver

A gentle multichannel current carries the medicine into the tissue and keeps delivering — continuously, right where it’s needed.

The same precise ion control powers our air-purification and respiratory systems.

The evidence

Published, patented, and independently tested.

Across every application, the platform is published, patented, independently validated, and grant-supported.

Current activity: SBIR Phase I proposals submitted for the wound bandage and CBRN mask.

Tulane-validated: 99.8% of aerosolized SARS-CoV-2
LSU pre-clinical studies — needle-free anesthesia in ~4 min
Peer-reviewed in Viruses (2022)
Patented & patent-pending — incl. US 11,201,232 B2
NIH grant — TB-transmission control (mask work)
FDA-cleared predicate device — supports a 510(k) pathway
Independently validated at
TULANELSU
Grant support
NIH
How the technology works → Patents & publications →
The opportunity

A real need, met by a device simple enough to reach it.

99.8%
of aerosolized SARS-CoV-2 removed (Tulane)1
~4 min
needle-free dental anesthesia (LSU)2
>90%
of battlefield deaths occur before reaching care3
~25%
of those deaths are potentially survivable3

1. Tulane National Primate Research Center; Henley et al., Viruses 2022, 14(4):765.   2. LSU School of Dentistry pre-clinical studies.   3. Eastridge et al., “Death on the battlefield (2001–2011),” J Trauma Acute Care Surg 2012.

From point-of-injury care to clean indoor air, the same technology reaches markets that usually need entirely different companies to serve them.

Two platform technologies, one family of products

The product line.

Six products across two platform technologies — Electrokinetic Transdermal for the body and Corona Electrostatic Precipitation for the air — plus a point-of-care regenerative-cell device that isolates a patient's own stem cells without enzymes. From lab-validated prototypes toward first clinical and field trials, every one built on a shared, proven foundation.

Active Bandage — exploded view
Flagship

Active Bandage

Needle-free wound treatment that fights infection, slows bleeding, and manages pain at the point of injury.

Explore →
Dental — 24-channel electrode
Validated · LSU

Dental — Ionto-Pad

Pain-free, needle-free delivery of anesthetic and medication into the tooth and gum.

Explore →
In development

Cosmeceutical

Needle-free delivery into skin, follicle and gland — hair, lip anesthesia, and sweat mitigation.

Explore →
Respiratory — Ion Mask V3
Tulane-validated

Respiratory Protection

A hybrid mEP + charcoal canister that removed 99.8% of aerosolized SARS-CoV-2 at Tulane.

Explore →
In development

Air Purification

Clean-environment units for residential, commercial, and industrial HVAC.

Explore →
In development

Room Sanitizer

A room-scale unit that sanitizes air and surfaces across an entire space.

Explore →
Stem Cell Machine — bench device, mid isolation cycle
Patents granted

Stem Cell Machine

Point-of-care isolation of a patient's own regenerative cells — enzyme-free, in minutes.

Explore →

See the engineering renderings →

The breakthrough · needle-free delivery

Medicine that crosses the skin — on a current, not a needle.

A gentle electric field sets charged medicine in motion and carries it through the skin — molecule by molecule, all the way to the tissue below. No needle. No injection. No pain. Just physics doing the work a syringe used to.

Stratum corneum Epidermis Dermis Subcutaneous HENLEY · ELECTROKINETIC PAD multichannel · < 0.6 mA per channel + – capillary bed · nerve endings — the target NO NEEDLE
0
needles — nothing pierces the skin
~4 min
to anesthesia · LSU pre-clinical studies
<0.6 mA
a current you can barely feel

See how it works →   See it in the Active Bandage

drag to explore
Into the body

Medicine, delivered where the body needs it.

The same precise ion control that cleans the air drives medication through the skin and into the tissue — reaching the wound, not just resting on it. Drag to explore.

Dr. Julian Henley, MD
The inventor

A career of building medical firsts.

Henley Ion’s platform was invented by Dr. Julian Henley — educated at Harvard University (magna cum laude, Applied Mathematics & Physics) and the Albert Einstein College of Medicine.

A physician and board-certified specialty surgeon, he taught and practiced at Yale School of Medicine for 22 years. That depth is why a device this simple can do something this advanced.

Meet the inventor & team
Partner with us

We’re looking for development partners.

The science and the prototypes are in hand. What we need now are partners to help move them from the lab into the field — capital, distribution, clinical sites, or manufacturing.

Start a conversation →
CapitalDistributionClinical & trial sitesManufacturing